Welcome to LookChem.com Sign In|Join Free

CAS

  • or

185319-20-4

Post Buying Request

185319-20-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

185319-20-4 Usage

General Description

1-(2,6-dichloropyridin-4-yl)ethanone is a chemical compound that belongs to the class of pyridyl ketones. Its molecular formula is C7H5Cl2NO, and it has a molecular weight of 189.03 g/mol. 1-(2,6-dichloropyridin-4-yl)ethanone is used in various pharmaceutical and chemical applications, particularly as an intermediate in the synthesis of other compounds. It is also used as a building block in organic synthesis and as a reagent in chemical reactions. The dichloropyridinyl group in the molecule makes it useful in the development of new drugs and agrochemicals. This chemical can be hazardous if not handled properly and should be used in a controlled environment by trained personnel.

Check Digit Verification of cas no

The CAS Registry Mumber 185319-20-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,5,3,1 and 9 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 185319-20:
(8*1)+(7*8)+(6*5)+(5*3)+(4*1)+(3*9)+(2*2)+(1*0)=144
144 % 10 = 4
So 185319-20-4 is a valid CAS Registry Number.

185319-20-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-(2,6-dichloropyridin-4-yl)ethanone

1.2 Other means of identification

Product number -
Other names 1-(2,6-DICHLOROPYRIDIN-4-YL)ETHAN-1-ONE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:185319-20-4 SDS

185319-20-4Relevant articles and documents

Design, synthesis and anticancer properties of isocombretapyridines as potent colchicine binding site inhibitors

Shuai, Wen,Li, Xinnan,Li, Wenlong,Xu, Feijie,Lu, Lixue,Yao, Hong,Yang, Limei,Zhu, Huajian,Xu, Shengtao,Zhu, Zheying,Xu, Jinyi

, (2020)

A series of novel isocombretapyridines were designed and synthesized based on a lead compound isocombretastatin A-4 (isoCA-4) by replacing 3,4,5-trimethoxylphenyl with substituent pyridine nucleus. The MTT assay results showed that compound 20a possessed the most potent activities against all tested cell lines with IC50 values at nanomolar concentration ranges. Moreover, 20a inhibited tubulin polymerization at a micromolar level and also displayed potent anti-vascular activity in vitro. Further mechanistic studies were conducted to demonstrate that compound 20a could bind to the colchicine site of tubulin,and disrupte the cell microtubule networks, induce G2/M phase arrest, promote apoptosis and depolarize mitochondria of K562 cells in a dose-dependent manner. Notably, 20a exhibited more potent tumor growth inhibition activity with 68.7% tumor growth inhibition than that of isoCA-4 in H22 allograft mouse model without apparent toxicity. The present results suggested that compound 20a may serve as a promising potent microtubule-destabilizing agent candidate for the development of therapeutics to treat cancer.

POTASSIUM CHANNEL MODULATORS

-

Paragraph 0442; 0444, (2018/01/14)

Provided are novel compounds of Formula (I): and pharmaceutically acceptable salts thereof, which are useful for treating a variety of diseases, disorders or conditions, associated with potassium channels. Also provided are pharmaceutical compositions comprising the novel compounds of Formula (I), pharmaceutically acceptable salts thereof, and methods for their use in treating one or more diseases, disorders or conditions, associated with potassium channels.

AMINOPYRAZINE DERIVATIVE AND MEDICINE

-

Page/Page column 31, (2011/12/12)

The present invention relates to a compound represented by general formula [1] satisfying the following (I) or (II), or a pharmaceutical acceptable salt of the compound. (I) X is CH or N; R1 is a halogen atom,; and R2 is H, a halogen atom, CN, [2], [3], [8], [9], an —O-alkyl, an —O-(saturated ring), etc. [2]: —C(RC)(RD)(RE) (RC to RE each are H, an alkyl, etc.) [3]: —N(RF)(RG) (RF and RG each are H, OH, amino, a (hetero)aryl, etc.) [8]: —C(═O)RL (RL is an alkyl, OH, an alkoxy, amino, etc.) [9]: a (substituted)phenyl; (II) X is >C—C(—O)R3 (R3 is a (substituted)amino, an alkoxy, OH, etc.); R1 is a halogen atom; R2 is H; R3 is H or OH; and R3 and R4 each are H or an alkyl.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 185319-20-4